Last Updated : February 27, 2014
Details
FilesGeneric Name:
Pasireotide diaspartate
Project Status:
Complete
Therapeutic Area:
Cushing’s disease
Manufacturer:
Novartis Pharmaceuticals Inc.
Call for patient/clinician input open:
Brand Name:
Signifor
Project Line:
Reimbursement Review
Project Number:
SR0372-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Submission Type:
Initial
Indications:
Cushing’s Disease
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : February 27, 2014